Lower riskMedical device recall · FDA · Published January 29, 2021
Confirm Biosciences Recalls Healgen COVID-19 Test Cassette for In-Home Use Safety
Confirm Biosciences recalls Healgen COVID-19 IgG/IgM Rapid Test Cassette (REF GCC)V-402a due to distribution outside Emergency Use Authorization and inadequate validation for fingerstick home testing. Affected units include specific lot numbers.
Due to two (2) issues: 1) The firm distributed COVID-19 Rapid Test Cassettes outside of the Emergency Use Authorization to non-certified Clinical Laboratories. 2) COVID-19 Rapid Test Cassettes were not adequately validated for its intended use (fingerstick tests for in-home use/testing).
Take action
Contact the company
📍Recalling firmConfirm Biosciences Inc10123 Carroll Canyon Rd · San Diego, CA 92131-1109
✎ GovInfoNow plain-language explainer
Confirm Biosciences is recalling Healgen COVID-19 IgG/IgM Rapid Test Cassettes (REF GCC)V-402a because they were distributed to non-certified labs and not properly validated for home fingerstick use. This could lead to inaccurate results if used by consumers at home. Read more at govinfonow.com/recall/63333-confirm-biosciences-recalls-healgen-covid-19-test-cassette-for-in.
“Confirm Biosciences Recalls Healgen COVID-19 Test Cassette for In-Home Use Safety.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63333-confirm-biosciences-recalls-healgen-covid-19-test-cassette-for-in. Based on FDA recall #Z-1125-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1125-2021%22&limit=1).
The FDA announced on Jan. 29, 2021, that Confirm Biosciences Inc voluntarily recalled its Healgen COVID-19 IgG/IgM Rapid Test Cassettes due to distribution outside Emergency Use Authorization and inadequate validation for intended use. The agency classified the recall as Class II.
How to tell if you have it
Brand: Confirm Biosciences
Product: Healgen COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma)
REF: GCC)V-402a
Catalog Number: HE Cassette COVID 19EUA
Lot Numbers: 2006167eua, 2006168eua, 2006169eua
Units affected: 563,840 cassettes
The hazard
The recall addresses two issues: the distribution of test cassettes to non-certified Clinical Laboratories outside of Emergency Use Authorization and the lack of adequate validation for fingerstick tests intended for in-home use. The FDA said these defects compromise the device's reliability for its specific purposes.
Context
GovInfoNow's records show other recent recalls include GET TESTED Continuous Glucose Monitors (2025-11-03), Vivoo Test Strips (2025-11-22), and GET TESTED H. pylori Test (2025-11-03).
How to tell if you have this one
Check the lot number on the cassette: 2006167eua, 2006168eua, or 2006169eua. The product is a lateral flow immunoassay for detecting SARS-CoV-2 antibodies in whole blood, serum, or plasma.
Brand
Confirm Biosciences
Category
Medical device
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Terminated
Distribution
Worldwide distribution - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV and WY. The countries of Australia, Mexico, Honduras, Spain, Sierra Leone, Bahamas, Ecuador, Turkey, Romania, Kuwait, Libya, Qatar, Ghana, Argentina, Bolivia, Brazil, Guatemala, Panama, India, United Kingdom, West Indies, South Africa, United Arab Emirates, Slovenia, Canada, Israel, United Kingdom, Romania, Argentina, Honduras, Russian Federation, R¿publique D¿mocratique du Congo, Switzerland, Dominican Republic, Greece, Saudi Arabia, and Portugal.
Recall number
Product, codes & lots
Quantity
Z-1125-2021
Healgen COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) REF GCC)V-402a - Product Usage: is a lateral flow immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV- 2 in human venous whole blood, plasma from anticoagulated blood or serum.; Catalog Number: HE Cassette COVID 19EUA Lot Numbers: 2006167eua 2006168eua 2006169eua
563,840 cassettes
Z-1126-2021
Orient Gene COVID- 19 IgG/ IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) REF GCCOV-402a - Product Usage: is a lateral flow immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV- 2 in human venous whole blood, plasma from anticoagulated blood or serum.; Catalog Number: HE Cassette COVID 19 Lot Numbers: 2002198, 2003244, 2003285, 2003290, 2003291, 2003295, 2003308, 2004148, 2004158, 2005153, 2005154, 2005155, 2005213
2,003,053 cassettes
Based on the official FDA remedy
What to do — step by step
Check Lot Number
Look for lot numbers 2006167eua, 2006168eua, or 2006169eua on the cassette packaging.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 47 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide distribution - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, Wyoming.
Recall timeline
FDA terminated this recall 22 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1125-2021 (January 29, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1125-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.